Literature DB >> 14661090

Maillard reaction products in tissue proteins: new products and new perspectives.

S R Thorpe1, J W Baynes.   

Abstract

The chemical modification of protein by nonenzymatic browning or Maillard reactions increases with age and in disease. Maillard products are formed by reactions of both carbohydrate- and lipid-derived intermediates with proteins, leading to formation of advanced glycation and lipoxidation end-products (AGE/ALEs). These modifications and other oxidative modifications of amino acids increase together in proteins and are indicators of tissue aging and pathology. In this review, we describe the major pathways and characteristic products of chemical modification of proteins by carbohydrates and lipids during the Maillard reactions and identify major intersections between these pathways. We also describe a new class of intracellular sulfhydryl modifications, Cys-AGE/ALEs, that may play an important role in regulatory biology and represent a primitive link between nonenzymatic and enzymatic chemistry in biological systems.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14661090     DOI: 10.1007/s00726-003-0017-9

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  119 in total

1.  Exceptionally old mice are highly resistant to lipoxidation-derived molecular damage.

Authors:  Lorena Arranz; Alba Naudí; Mónica De la Fuente; Reinald Pamplona
Journal:  Age (Dordr)       Date:  2012-02-25

Review 2.  Diabetic periodontitis: a model for activated innate immunity and impaired resolution of inflammation.

Authors:  Hamdy Nassar; Alpdogan Kantarci; Thomas E van Dyke
Journal:  Periodontol 2000       Date:  2007       Impact factor: 7.589

3.  AGE-RAGE Stress in the Pathophysiology of Atrial Fibrillation and Its Treatment.

Authors:  Kailash Prasad
Journal:  Int J Angiol       Date:  2019-12-09

4.  Identification of a metabolic disposal route for the oncometabolite S-(2-succino)cysteine in Bacillus subtilis.

Authors:  Thomas D Niehaus; Jacob Folz; Donald R McCarty; Arthur J L Cooper; David Moraga Amador; Oliver Fiehn; Andrew D Hanson
Journal:  J Biol Chem       Date:  2018-04-06       Impact factor: 5.157

5.  Advanced glycation end product modification of bone proteins and bone remodelling: hypothesis and preliminary immunohistochemical findings.

Authors:  G Hein; C Weiss; G Lehmann; T Niwa; G Stein; S Franke
Journal:  Ann Rheum Dis       Date:  2006-01       Impact factor: 19.103

6.  Modulation of advanced glycation endproduct synthesis by kynurenines in human lens proteins.

Authors:  Ram H Nagaraj; Smitha Padmanabha; Maneesh Mailankot; Magdalena Staniszewska; Liew Jun Mun; Marcus A Glomb; Mikhail D Linetsky
Journal:  Biochim Biophys Acta       Date:  2009-12-22

Review 7.  Oxidative stress as a mechanism of added sugar-induced cardiovascular disease.

Authors:  Kailash Prasad; Indu Dhar
Journal:  Int J Angiol       Date:  2014-12

Review 8.  Site-specific AGE modifications in the extracellular matrix: a role for glyoxal in protein damage in diabetes.

Authors:  Paul Voziyan; Kyle L Brown; Sergei Chetyrkin; Billy Hudson
Journal:  Clin Chem Lab Med       Date:  2014-01-01       Impact factor: 3.694

Review 9.  RAGE: a novel target for drug intervention in diabetic vascular disease.

Authors:  Barry I Hudson; Ann Marie Schmidt
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

10.  Pioglitazone ameliorates memory deficits in streptozotocin-induced diabetic mice by reducing brain β-amyloid through PPARγ activation.

Authors:  Li-ping Liu; Tian-hua Yan; Li-ying Jiang; Wei Hu; Meng Hu; Chao Wang; Qian Zhang; Yan Long; Jiang-qing Wang; Yong-qi Li; Mei Hu; Hao Hong
Journal:  Acta Pharmacol Sin       Date:  2013-03-25       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.